Breast lumps differential diagnosis: Difference between revisions

	Breast lumps Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Breast lumps from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Breast lumps differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Breast lumps differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Breast lumps differential diagnosis
on Breast lumps differential diagnosis
Breast lumps differential diagnosis in the news
Blogs on Breast lumps differential diagnosis
Directions to Hospitals Treating Breast lumps
Risk calculators and risk factors for Breast lumps differential diagnosis

VisualWikitext

Revision as of 01:25, 14 January 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Breast lumps must be differentiated from other diseases such as malignancy, cysts, inflammation and non-inflammatory solid lumps.

Breast symptoms such as nipple discharge and mastalgia require assessment as well ^[1].

Differentiating Breast lumps from other Diseases

Differential diagnosis of breast lumps include: ^[1]

Malignancy or breast cancer
- Associated with following factors^[2]:
  - Geographical area
  - Age
  - Ethnicity
  - Positive family history
  - Pathology results such as:
    - Atypical ductal hyperplasia (ADH)
    - Atypical lobular hyperplasia (ALH)
    - Lobular carcinoma in situ (LCIS)
  - Previous history of radiotherapy
Inflammatory lumps:^[3]^[4]
- Associated to personal habit and disease pattern:
  - Infective lumps
    - Lactational mastitis or abscess
    - Non-lactational mastitis
      - Periductal mastitis in chronic smokers
      - Lobular mastitis in tuberculosis and parasitic infection
  - Non-infective lumps such as chronic granulomatous infection
Solid non-inflammatory lumps ^[5] ^[6]
- Related to age, geographical area and ethnicity
- Mostly fibroadenomas in women aged 20-30 years
- Phyllodes tumor are prevalent in various centers, racial groups in different frequencies
Cysts^[7]
- Related to age and usage of hormonal replacement therapy
- Symptomatic cysts are often seen in women age 30 years to early 50 years
- If menopausaed women may be present due to hormone replacement therapy (HRT)

Differential diagnosis of breast lumps
Benign	Palpable breast masses in women between 20 to 50 years old^[8]The most common types of benign breast lumps are^[9]: Fibroadenoma Cysts Fibrocystic changes Galactocele Fat necrosis Breast abscess
Malignant	The most common types are infiltrating ductal breast carcinoma, infiltrating lobular breast carcinoma, mixed of ductal and lobular carcinoma and usually present as a hard mass in breast^[10]

Differentiating Breast lumps from other Diseases

Diseases	Clinical manifestation									Paraclinical findings
	Demography	History	Symptoms			Signs				Paraclinical findings
	Demography	History	Mass	Pain	Nipple discharge	Breast exam	Skin changes	LAP	Others	Lab findings	Histopathology	Imaging
Fibroadenoma
Breast cyst
Fibrocystic change
Galactocele
Cysts of montgomery
Hemangioma
Breast abscess
Mastitis
Breast carcinoma
Ductal carcinoma in situ
Microinvasive breast cancer
Breast sarcoma
Paget disease
Phyllodes tumor
Lymphoma
Metastasis
Duct ectasia
Intraductal papilloma
Lipoma
Neurofibroma
Pregnancy
Gynecomastia
Premenstrual syndrome
Breast trauma
Fat necrosis
Drugs

References

↑ ^1.0 ^1.1 Cheung KL, Lam TP (2005). "Approach to a lump in the breast: a regional perspective". Asian J Surg. 28 (1): 65–70. doi:10.1016/S1015-9584(09)60264-5. PMID 15691804.
↑ Collyar DE (2001). "Breast cancer: a global perspective". J Clin Oncol. 19 (18 Suppl): 101S–105S. PMID 11560983.
↑ Lang AP, Luchsinger IS, Rawling EG (1987). "Filariasis of the breast". Arch Pathol Lab Med. 111 (8): 757–9. PMID 3307689.
↑ Varghese R, Raghuveer CV, Pai MR, Bansal R (1996). "Microfilariae in cytologic smears: a report of six cases". Acta Cytol. 40 (2): 299–301. doi:10.1159/000333755. PMID 8629415.
↑ Alagaratnam, T.T. & Wong, J. World J. Surg. (1989) 13: 743. https://doi.org/10.1007/BF01658425
↑ Shukla HS, Kumar S (1989). "Benign breast disorders in nonwestern populations: Part II--Benign breast disorders in India". World J Surg. 13 (6): 746–9. PMID 2623884.
↑ Leung TN, Haines CJ, Chung TK (2001). "Five-year compliance with hormone replacement therapy in postmenopausal Chinese women in Hong Kong". Maturitas. 39 (3): 195–201. PMID 11574178.
↑ Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998). "Ten-year risk of false positive screening mammograms and clinical breast examinations". N Engl J Med. 338 (16): 1089–96. doi:10.1056/NEJM199804163381601. PMID 9545356.
↑ Morrow M (2000). "The evaluation of common breast problems". Am Fam Physician. 61 (8): 2371–8, 2385. PMID 10794579.
↑ Schoonjans JM, Brem RF (2001). "Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses". J Ultrasound Med. 20 (9): 967–72. PMID 11549157.

Template:WH Template:WS

[pmid15691804-1] 1.0 ^1.1 Cheung KL, Lam TP (2005). "Approach to a lump in the breast: a regional perspective". Asian J Surg. 28 (1): 65–70. doi:10.1016/S1015-9584(09)60264-5. PMID 15691804.

[pmid11560983-2] Collyar DE (2001). "Breast cancer: a global perspective". J Clin Oncol. 19 (18 Suppl): 101S–105S. PMID 11560983.

[pmid3307689-3] Lang AP, Luchsinger IS, Rawling EG (1987). "Filariasis of the breast". Arch Pathol Lab Med. 111 (8): 757–9. PMID 3307689.

[pmid8629415-4] Varghese R, Raghuveer CV, Pai MR, Bansal R (1996). "Microfilariae in cytologic smears: a report of six cases". Acta Cytol. 40 (2): 299–301. doi:10.1159/000333755. PMID 8629415.

[5] Alagaratnam, T.T. & Wong, J. World J. Surg. (1989) 13: 743. https://doi.org/10.1007/BF01658425

[pmid2623884-6] Shukla HS, Kumar S (1989). "Benign breast disorders in nonwestern populations: Part II--Benign breast disorders in India". World J Surg. 13 (6): 746–9. PMID 2623884.

[pmid11574178-7] Leung TN, Haines CJ, Chung TK (2001). "Five-year compliance with hormone replacement therapy in postmenopausal Chinese women in Hong Kong". Maturitas. 39 (3): 195–201. PMID 11574178.

[pmid9545356-8] Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998). "Ten-year risk of false positive screening mammograms and clinical breast examinations". N Engl J Med. 338 (16): 1089–96. doi:10.1056/NEJM199804163381601. PMID 9545356.

[pmid10794579-9] Morrow M (2000). "The evaluation of common breast problems". Am Fam Physician. 61 (8): 2371–8, 2385. PMID 10794579.

[pmid115491572-10] Schoonjans JM, Brem RF (2001). "Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses". J Ultrasound Med. 20 (9): 967–72. PMID 11549157.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

@@ Line 54: / Line 54: @@
 {|
-! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
 ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
 ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
@@ Line 80: / Line 79: @@
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
 |-
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
 ! align="center" style="background:#DCDCDC;" |Fibroadenoma
 | align="center" style="background:#F5F5F5;" |
@@ Line 100: / Line 98: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Breast cyst
 | align="center" style="background:#F5F5F5;" |
@@ Line 120: / Line 117: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Fibrocystic change
 | align="center" style="background:#F5F5F5;" |
@@ Line 140: / Line 136: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Galactocele
 | align="center" style="background:#F5F5F5;" |
@@ Line 160: / Line 155: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Cysts of montgomery
 | align="center" style="background:#F5F5F5;" |
@@ Line 180: / Line 174: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |[[Hemangioma]]
 | align="center" style="background:#F5F5F5;" |
@@ Line 200: / Line 193: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Breast abscess
 | align="center" style="background:#F5F5F5;" |
@@ Line 220: / Line 212: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Mastitis
 | align="center" style="background:#F5F5F5;" |
@@ Line 240: / Line 231: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Breast carcinoma
 | align="center" style="background:#F5F5F5;" |
@@ Line 260: / Line 250: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Ductal carcinoma in situ
 | align="center" style="background:#F5F5F5;" |
@@ Line 280: / Line 269: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Microinvasive breast cancer
 | align="center" style="background:#F5F5F5;" |
@@ Line 300: / Line 288: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Breast sarcoma
 | align="center" style="background:#F5F5F5;" |
@@ Line 320: / Line 307: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Paget disease
 | align="center" style="background:#F5F5F5;" |
@@ Line 340: / Line 326: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]
 | align="center" style="background:#F5F5F5;" |
@@ Line 360: / Line 345: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Lymphoma
 | align="center" style="background:#F5F5F5;" |
@@ Line 380: / Line 364: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Metastasis
 | align="center" style="background:#F5F5F5;" |
@@ Line 400: / Line 383: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Duct ectasia
 | align="center" style="background:#F5F5F5;" |
@@ Line 420: / Line 402: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]
 | align="center" style="background:#F5F5F5;" |
@@ Line 440: / Line 421: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Lipoma
 | align="center" style="background:#F5F5F5;" |
@@ Line 460: / Line 440: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |[[Neurofibroma]]
 | align="center" style="background:#F5F5F5;" |
@@ Line 480: / Line 459: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Pregnancy
 | align="center" style="background:#F5F5F5;" |
@@ Line 500: / Line 478: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Gynecomastia
 | align="center" style="background:#F5F5F5;" |
@@ Line 520: / Line 497: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Premenstrual syndrome
 | align="center" style="background:#F5F5F5;" |
@@ Line 540: / Line 516: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Breast trauma
 | align="center" style="background:#F5F5F5;" |
@@ Line 560: / Line 535: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Fat necrosis
 | align="center" style="background:#F5F5F5;" |
@@ Line 580: / Line 554: @@
 | align="center" style="background:#F5F5F5;" |
 |-
-!
 ! align="center" style="background:#DCDCDC;" |Drugs
 | align="center" style="background:#F5F5F5;" |

Breast lumps differential diagnosis: Difference between revisions

Revision as of 01:25, 14 January 2019

Overview

Differentiating Breast lumps from other Diseases

Differentiating Breast lumps from other Diseases

References

Navigation menu